These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
847 related articles for article (PubMed ID: 16601285)
41. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP. Uchida K; Masumori N; Takahashi A; Itoh N; Kato K; Matusik RJ; Tsukamoto T Prostate; 2006 Apr; 66(5):536-45. PubMed ID: 16372327 [TBL] [Abstract][Full Text] [Related]
42. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464 [TBL] [Abstract][Full Text] [Related]
43. The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue. Nakada SY; di Sant'Agnese PA; Moynes RA; Hiipakka RA; Liao S; Cockett AT; Abrahamsson PA Cancer Res; 1993 May; 53(9):1967-70. PubMed ID: 8481896 [TBL] [Abstract][Full Text] [Related]
44. Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivo. Palmer J; Ernst M; Hammacher A; Hertzog PJ Prostate; 2005 Feb; 62(3):282-9. PubMed ID: 15389784 [TBL] [Abstract][Full Text] [Related]
45. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271 [TBL] [Abstract][Full Text] [Related]
46. Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivation. Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ Prostate; 2002 Mar; 50(4):203-15. PubMed ID: 11870798 [TBL] [Abstract][Full Text] [Related]
47. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells. Xie S; Lin HK; Ni J; Yang L; Wang L; di Sant'Agnese PA; Chang C Prostate; 2004 Jun; 60(1):61-7. PubMed ID: 15129430 [TBL] [Abstract][Full Text] [Related]
48. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells. Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277 [TBL] [Abstract][Full Text] [Related]
49. Primary prostate cancer cultures are models for androgen-independent transit amplifying cells. Bühler P; Wolf P; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Freudenberg N; Elsässer-Beile U Oncol Rep; 2010 Feb; 23(2):465-70. PubMed ID: 20043108 [TBL] [Abstract][Full Text] [Related]
50. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells. Attardi BJ; Burgenson J; Hild SA; Reel JR Mol Cell Endocrinol; 2004 Jul; 222(1-2):121-32. PubMed ID: 15249132 [TBL] [Abstract][Full Text] [Related]
51. Secretagogin is a new neuroendocrine marker in the human prostate. Adolf K; Wagner L; Bergh A; Stattin P; Ottosen P; Borre M; Birkenkamp-Demtröder K; Orntoft TF; Tørring N Prostate; 2007 Apr; 67(5):472-84. PubMed ID: 17285592 [TBL] [Abstract][Full Text] [Related]
52. Expression and role of Foxa proteins in prostate cancer. Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449 [TBL] [Abstract][Full Text] [Related]
53. Interferon-gamma induces neuroendocrine-like differentiation of human prostate basal-epithelial cells. Untergasser G; Plas E; Pfister G; Heinrich E; Berger P Prostate; 2005 Sep; 64(4):419-29. PubMed ID: 15800938 [TBL] [Abstract][Full Text] [Related]
54. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response. Soto AM; Lin TM; Sakabe K; Olea N; Damassa DA; Sonnenschein C Oncol Res; 1995; 7(10-11):545-58. PubMed ID: 8866667 [TBL] [Abstract][Full Text] [Related]
55. Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice. DeMiguel F; Lee SO; Lou W; Xiao X; Pflug BR; Nelson JB; Gao AC Prostate; 2002 Jul; 52(2):123-9. PubMed ID: 12111703 [TBL] [Abstract][Full Text] [Related]
56. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Gleave M; Hsieh JT; Gao CA; von Eschenbach AC; Chung LW Cancer Res; 1991 Jul; 51(14):3753-61. PubMed ID: 1712249 [TBL] [Abstract][Full Text] [Related]
57. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells. Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells. He D; Falany CN Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250 [TBL] [Abstract][Full Text] [Related]
59. Neuroendocrine differentiation in human prostatic tumor models. Noordzij MA; van Weerden WM; de Ridder CM; van der Kwast TH; Schröder FH; van Steenbrugge GJ Am J Pathol; 1996 Sep; 149(3):859-71. PubMed ID: 8780390 [TBL] [Abstract][Full Text] [Related]
60. Androgen dependent regulation of protein kinase A subunits in prostate cancer cells. Kvissel AK; Ramberg H; Eide T; Svindland A; Skålhegg BS; Taskén KA Cell Signal; 2007 Feb; 19(2):401-9. PubMed ID: 16949795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]